A Study to Evaluate the Long-term Safety and Efficacy of Fenebrutinib in Participants Previously Enrolled in a Fenebrutinib Chronic Spontaneous Urticaria (CSU) Study
Clinical trial NCT03693625 · TERMINATED
Trial details
- NCT number
- NCT03693625
- Sponsor
- Genentech, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-27
- Primary completion
- 2019-10-23
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.